Connect to other sites within the UBM Medica Network
Cognitive Behavioral Therapy Reduced Survivors’ Memory-Related Issues
Cognitive behavioral therapy may reduce long-term memory-related issues linked to chemotherapy treatment in cancer survivors.
Assessing Critical Situations in Cancer Care
While oncologic emergencies are common among cancer patients, they can often be avoided with close monitoring, early intervention, and ongoing patient education.
Cancer Diagnosis Linked With Increased Risk of Mental Disorders
Cancer patients have an increased risk of several common mental disorders, including depression and anxiety, beginning almost a year prior to the diagnosis.
Risk Stratification, Corticosteroid Prophylaxis Reduces GVHD in Haploidentical Transplantation
Risk-stratification based on a biomarker and associated prophylaxis could help reduce the incidence of graft-vs-host disease in patients undergoing haploidentical transplantation.
Many Children Anxious, Depressed After ALL Treatment
A significant number of children who have completed treatment for acute lymphoblastic leukemia may be experiencing anxiety or depression, according to a new study.
FDA Approves First Drug for Severe Hepatic VOD After HSCT
The FDA has approved defibrotide sodium (Defitelio) for the treatment of hepatic veno-occlusive disease following hematopoietic stem cell transplantation in both adults and children.
Neurofeedback Can Reduce Symptoms Associated With CIPN
A brain-training paradigm called neurofeedback reduced pain and other symptoms associated with chronic chemotherapy-induced peripheral neuropathy.
By clicking Accept, you agree to become a member of the UBM Medica Community.